GC MEDIS Corp.

GC Medis Corp. specializes in in vitro diagnostic (IVD) devices primarily for glucose monitoring, hemoglobin measurement, and lactate testing. Their product range includes test strips, control solutions, and analyzers designed for both self-testing by patients and clinical use. Examples include blood glucose monitoring systems, hemoglobin measurement devices, HbA1c analyzers, and lactate measurement solutions.

GC Medis Corp. is based in South Korea. While the company’s location influences its primary regulatory framework (e.g., adherence to Korean medical device regulations), its devices listed in eudamed demonstrate compliance with EU requirements for IVD classification and registration. This means their products meet EU standards for safety, performance, and labeling, even though the company itself is not directly EU-approved.

GC Medis Corp.’s devices are registered in the eudamed database, the EU’s official registry for medical devices and IVDs. Listing here confirms their compliance with EU IVD regulations, including classification under Class A or Annex II List B (for certain diagnostic tests). This transparency helps healthcare providers, regulators, and patients verify the device’s authorized status in the EU market.

GC Medis Corp.’s devices fall under Class A (low-risk IVDs) and In Vitro Diagnostic (IVD) classifications, including Annex II List B (for certain diagnostic tests) and general IVD categories. Some products are designated for self-testing, meaning they are designed for use by patients outside clinical settings without professional supervision. Classification determines the regulatory scrutiny and labeling requirements for each device.